Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study

Samantha C. Burnham*, Nandini Raghavan, William Wilson, David Baker, Michael T. Ropacki, Gerald Novak, David Ames, Kathryn Ellis, Ralph N. Martins, Paul Maruff, Colin L. Masters, Gary Romano, Christopher C. Rowe, Greg Savage, S. Lance Macaulay, Vaibhav A. Narayan, Alzheimer's Disease Neuroimaging Initiative, The AIBL Research Group

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    25 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Social Sciences